KidneyX Phase 1 Receives 165 Funding Applications

The KidneyX partnership between HHS and the American Society of Nephrology asked for ways to replace kidney function and boost quality of life. Up to 15 Phase 1 awards of $75,000 for the best prototypes are expected, followed three $500,000 Phase 2 awards.

Read the full article » | Posted 04-11-2019

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026